Clinical Trial Update: Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (VITAC) evaluated tacrolimus for efficacy in adults with facial non-segmental vitiligo and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Vitiligo | Phase 3 | Status: COMPLETED